<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39377782</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-3265</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Clinical cancer research : an official journal of the American Association for Cancer Research</Title><ISOAbbreviation>Clin Cancer Res</ISOAbbreviation></Journal><ArticleTitle>FDA Approval Summary: Capecitabine Labeling Update under Project Renewal.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1158/1078-0432.CCR-24-1708</ELocationID><Abstract><AbstractText>On December 14, 2022, the U.S. Food and Drug Administration (FDA) approved revisions to the United States Prescribing Information (USPI) for capecitabine that revised existing indications and dosage regimens, added new indications and their recommended dosage regimens, revised safety information, updated the description of the risk of capecitabine in patients with dihydropyrimidine dehydrogenase (DPD) deficiency, and edited other sections of the USPI to conform with FDA's current labeling guidance. These supplements were reviewed and approved under Project Renewal, a public health initiative established by the FDA's Oncology Center of Excellence that aims to update the prescribing information of certain older oncology drugs to ensure information is clinically meaningful and scientifically up to date. This article summarizes the FDA approach that supported revisions to the capecitabine USPI within the context of Project Renewal.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Sundeep</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5447-8590</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Clara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0009-4080-5317</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, Maryland, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierce</LastName><ForeName>William F</ForeName><Initials>WF</Initials><Identifier Source="ORCID">0000-0002-3411-7720</Identifier><AffiliationInfo><Affiliation>Food and Drug Administration, Silver Spring, Maryland, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Everhart</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0000-0306-2985</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King-Ducre</LastName><ForeName>Adriene</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0000-1904-5629</Identifier><AffiliationInfo><Affiliation>Food and Drug Administration, Silver Spring, Maryland, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Royce</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7173-1295</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, Maryland, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osgood</LastName><ForeName>Christy L</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0001-7450-9342</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amiri-Kordestani</LastName><ForeName>Laleh</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0056-5437</Identifier><AffiliationInfo><Affiliation>Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Haw-Jyh</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0009-0004-4814-6110</Identifier><AffiliationInfo><Affiliation>Food and Drug Administration, Silver Spring, Maryland, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricks</LastName><ForeName>Tiffany K</ForeName><Initials>TK</Initials><Identifier Source="ORCID">0000-0003-2026-0996</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Lili</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7346-7387</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, Maryland, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fourie Zirkelbach</LastName><ForeName>Jeanne</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3915-8668</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, Maryland, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charlab</LastName><ForeName>Rosane</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8676-1593</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacanowski</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0004-2620-7779</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tamy</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0001-8196-6688</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pazdur</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4771-9923</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluetz</LastName><ForeName>Paul G</ForeName><Initials>PG</Initials><Identifier Source="ORCID">0000-0002-9796-4791</Identifier><AffiliationInfo><Affiliation>Food and Drug Administration, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Jennifer J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0003-1153-545X</Identifier><AffiliationInfo><Affiliation>United States Food and Drug Administration, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Cancer Res</MedlineTA><NlmUniqueID>9502500</NlmUniqueID><ISSNLinking>1078-0432</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39377782</ArticleId><ArticleId IdType="doi">10.1158/1078-0432.CCR-24-1708</ArticleId><ArticleId IdType="pii">748871</ArticleId></ArticleIdList></PubmedData></PubmedArticle>